Abstract
Brain and other CNS tumors are the most common types of cancer in children aged 0–14 years, with an annual age-adjusted incidence rate of 5.47 per 100,000, and also the leading cause of cancer-related death in this age group, having recently surpassed leukemia in the US cancer registry. Brain cancer among the adult population accounts for 1.4% of all new cancers and 2.8% of all cancer deaths, with an annual incidence of 6.4 cases per 100,000 adults. Taking into consideration all primary brain and nervous system tumors in adults, the US incidence rate is estimated to be 29.18 per 100,000 population with approximately one-third of tumors being malignant and the remainder being benign or borderline malignant [1, 2]. The most common intracranial tumor is brain metastasis. They are ten times more frequent than primary brain tumors, and their incidence is increasing during the past decades, most probably due to the increased availability of brain imaging. More than 75% of the primary brain tumors are gliomas and meningiomas.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ostrom TQ, Gittleman H, Xu J et al (2016) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013. Neuro Oncol 18(suppl_5):v1–v75
National Cancer Institute, SEER Cancer Statistics Review (CSR) 1975–2014. Released April 2017
Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820
Norden AD, Wen YP, Kesari S (2005) Brain metastases. Curr Opin Neurol 18:654–661
Diener-West M, Dobbins TW, Phillips TL et al (1989) Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 16(3):669–673
Lagerwaard FJ, Levendag PC, Nowak PJ et al (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43(4):795–803
Louis DN (2006) Molecular pathology of malignant gliomas. Annu Rev Pathol 1:97–117
Riemenschneider MJ, Jeuken JW, Wesseling P et al (2010) Molecular diagnostics of gliomas: state of the art. Acta Neuropathol 120(5):567–584
Towner RA, Jensen RL, Colman H et al (2012) ELTD1, a potential new biomarker for gliomas. Neurosurgery 72:77
Stewart LA (2002) Chemotherapy in adult high- grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359(9311):1011–1018
Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64(6):479–489
Lamszus K (2004) Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63(4):275–286
Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neuro-Oncol 70(2):183–202
Perry A, Banerjee R, Lohse CM et al (2002) A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol 12(2):183–190
Zamora C, Castillo M (2017) Sellar and parasellar imaging. Neurosurgery 80(1):17–38
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Nomikos, P.V., Antoniadis, I.S. (2018). Introduction to Brain Tumors. In: Gouliamos, A., Andreou, J., Kosmidis, P. (eds) Imaging in Clinical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-68873-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-68873-2_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-68872-5
Online ISBN: 978-3-319-68873-2
eBook Packages: MedicineMedicine (R0)